Post job

Competitor Summary. See how Hudson Valley Properties compares to its main competitors:

  • Economic Transformation Technologies has the most employees (3,000).
Work at Hudson Valley Properties?
Share your experience

Hudson Valley Properties vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
-
3.5
--$75.0M50
-
4.1
New York, NY1$5.8M50
2012
3.7
San Juan, PR1$690,00050
Open Society
-
4.5
Indianapolis, IN1$2.1M10
-
3.5
Frisco, TX1$5.8M3,000
Icb International Inc
-
4.2
Los Angeles, CA1$900,00012
-
3.6
Allentown, PA1$690,00050
ENGAGE International
-
4.4
Barrington, IL1$260,0005

Rate how well Hudson Valley Properties differentiates itself from its competitors.

Zippia waving zebra

Hudson Valley Properties salaries vs competitors

Compare Hudson Valley Properties salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Hudson Valley Properties
$61,506$29.57-

Compare Hudson Valley Properties job title salaries vs competitors

CompanyHighest salaryHourly salary
Hudson Valley Properties
$70,506$33.90
International Typeface Corp.
$78,418$37.70
Economic Transformation Technologies
$70,506$33.90
mynetwork
$70,504$33.90
Open Society
$70,500$33.89
ENGAGE International
$70,495$33.89
Bifrost
$70,494$33.89
Icb International Inc
$70,468$33.88

Do you work at Hudson Valley Properties?

Is Hudson Valley Properties able to compete effectively with similar companies?

Hudson Valley Properties jobs

0

Hudson Valley Properties and similar companies CEOs

CEOBio
Ram Bhatt
Icb International Inc

Bhatt is a veteran of the biotechnology industry with more than 30 years of experience in pharmaceutical development and diagnostics. At Hoffman-La Roche, he developed human IL-2, gamma-Interferon and Human Growth Hormone Releasing Factor pharmaceuticals. He developed a diagnostic for sexually transmitted diseases and the key components of HPA technology, which generate more than $500 million a year in commercial diagnostic revenue for Gen-Probe. For Biocept, Dr. Bhatt developed a non-invasive diagnostic test for fetal RhD genotyping and a fetal gender-determination test from maternal blood at eight to nine weeks gestation. He invented and developed a novel device to capture and analyze circulating fetal cells and tumor cells to diagnose prenatal disorders and cancers. Dr. Bhatt has served as a member of the National Institutes of Health Grant Review Board.

As an accomplished executive with over 25 years of operations, management, and consulting expertise, Kelly specializes in introducing new transformational strategies and innovative business solutions that evolve operating models and spawn new profitable revenue sources. - Executive Advisor and Management Consultant- Global Enterprise & Sales Management (US&C, EMEA, APAC, and LATAM)- Commercial Industry Expertise (Healthcare & Life Sciences, Travel & Transportation, and Banking)- Financial / P&L Responsibility Exceeding $1 billion- Strategic Account and Client Management- Industry Verticalization and Solution Ideation - Alliance Management and Collaborative Offering DevelopmentOver his career, Kelly has held executive leadership positions at GlaxoSmithKline, EDS, Unisys, Tech Mahindra, and IMS Health.

Hudson Valley Properties competitors FAQs

Search for jobs